Today’s Clinical Trials Define the Next Era in Myeloma
Update: 2025-08-22
Description
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
